Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92744372 | 9274437 | 2 | F | 20111021 | 20160721 | 20130506 | 20160726 | EXP | BR-AMGEN-BRACT2012001145 | AMGEN | 50.00 | YR | A | F | Y | 75.00000 | KG | 20160726 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92744372 | 9274437 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, 1X/WEEK | N | G30365 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92744372 | 9274437 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92744372 | 9274437 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92744372 | 9274437 | Anaemia | |
| 92744372 | 9274437 | Dengue fever | |
| 92744372 | 9274437 | Injection site pain | |
| 92744372 | 9274437 | Injection site warmth | |
| 92744372 | 9274437 | Platelet count decreased | |
| 92744372 | 9274437 | Urinary tract infection | |
| 92744372 | 9274437 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92744372 | 9274437 | 1 | 201101 | 201111 | 0 |